The Role of Platelet-Rich Plasma in Biomedicine: A Comprehensive Overview
Zhixin Zhang,
No information about this author
Peng Liu,
No information about this author
Xinmiao Xue
No information about this author
et al.
iScience,
Journal Year:
2025,
Volume and Issue:
28(2), P. 111705 - 111705
Published: Jan. 5, 2025
Biomedicine
has
seen
significant
advancements
in
the
21st
century,
with
platelet-rich
plasma
(PRP)
playing
a
crucial
role
clinical
practice.
This
blood
derivative,
enriched
platelet
components,
shown
great
potential
for
promoting
tissue
repair
and
regeneration.
Its
wide
range
of
applications
presence
anti-inflammatory
growth-promoting
factors
make
it
valuable
tool
field
biomedicine.
The
exploration
PRP
settings
been
gaining
momentum.
Despite
its
cost-effectiveness,
safety,
therapeutic
efficacy,
widespread
adoption
hindered
by
absence
consistent
preparation
standards
standardized
treatment
protocols.
article
provides
comprehensive
analysis
uses,
physiological
roles,
molecular
mechanisms,
techniques
aim
is
to
offer
thorough
understanding
benefits
medical
Language: Английский
Sensitivity and Specificity Analysis of Different Lesion Areas of Vitiligo by Reflectance Confocal Microscopy
Jiyuan Wu,
No information about this author
Miaomiao Sun,
No information about this author
Zijia Wei
No information about this author
et al.
Journal of Cosmetic Dermatology,
Journal Year:
2025,
Volume and Issue:
24(2)
Published: Feb. 1, 2025
ABSTRACT
Background
Clinical
diagnosis
and
staging
of
vitiligo
often
rely
on
the
patient's
subjective
recollection,
physician's
experience,
or
clinical
evaluation
methods.
An
objective,
quantitative
diagnostic
approach
is
lacking.
Aims
This
study
was
performed
to
compare
sensitivity
specificity
different
lesion
areas
full
scanning
using
reflectance
confocal
microscopy
(RCM)
for
vitiligo.
Methods
RCM
data
patients
diagnosed
with
were
collected.
gathered
from
three
sites
a
lesion:
center
lesion,
margin
perilesional
normal
skin.
Scoring
conducted
each
method,
categorizing
results
as
either
progressive
stable
stage
Results
The
significantly
lower
in
skin
than
at
multiple
(
p
<
0.001).
higher
0.05
all).
Conclusions
showed
that
rate
missed
lowest
comparable
sites.
misdiagnosis
skin,
differing
other
Overall,
yielded
most
accurate
results,
offering
flexibility
selection
according
compliance.
Language: Английский
Clinical and dermoscopic assessment of the efficacy of topical trichloroacetic acid 70% versus methoxsalen 0.2% paint in stable acral vitiligo
Ahmed R. Elshahed,
No information about this author
Amr Mohammad Ammar,
No information about this author
Abdallah Mamdouh lotfy Ali
No information about this author
et al.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Feb. 8, 2025
Abstract
Loss
and
absence
of
melanocytes
due
to
a
number
factors
is
responsible
for
vitiligo;
known
be
the
commonest
disorder
pigmentation.
The
aim
study
was
assess
clinically
dermoscopically
efficacy
topical
trichloroacetic
acid
70%
versus
methoxsalen
0.2%
paint
in
stable
acral
vitiligo.
patients
were
randomly
divided
into
2
groups.
Group
(
n
=
35)
received
every
other
day
4
months
duration
with
dermoscopic
follow
up
while
group
b
TCA
application
at
clinic
two
weeks
up.
majority
subjects
both
groups
experienced
either
no
or
mild
improvement.
In
group,
mean
improvement
4.0
±
11.6%
range
0–60%
0.57
3.3%
0–20%
p
0.051).
reported
poor
satisfaction.
Both
modalities
did
not
demonstrate
significant
clinical
nor
response.
had
lower
effective
rate
than
studies
probably
resistance
vitiliginous
lesions
treatment
comparison
sites
body.
Further
larger
multi
centre
different
concentration
combination
are
required
detect
promising
treatments
vitligo.
Language: Английский
Dermatological Indications: Vitiligo
Published: Jan. 1, 2025
Recent trends in the treatment of vitiligo using novel drug delivery system
Nandita Sahu,
No information about this author
Parag Jain,
No information about this author
Deepika Sahu
No information about this author
et al.
International Journal of Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
unknown, P. 125106 - 125106
Published: Dec. 1, 2024
Language: Английский
Manejo do vitiligo baseado em evidências: resumo de uma revisão sistemática
Barbara Marin Augusto,
No information about this author
Caroline Santos,
No information about this author
Mariana da Silveira Castro
No information about this author
et al.
Journal Archives of Health,
Journal Year:
2024,
Volume and Issue:
5(3), P. e2116 - e2116
Published: Aug. 1, 2024
Introdução:
O
vitiligo
é
uma
doença
de
pele
despigmentante
crônica,
não
sendo
totalmente
compreendida
em
seu
ponto
vista
etiopatogênico.
Além
disso,
possui
possibilidade
tratamento
ainda
limitada
e
pouco
específica.
Devido
ao
fato
ser
estigmatizante
com
tratamentos
específicos,
o
presente
artigo
tem
como
objetivo
revisão
sistemática
baseada
evidências
sobre
manejo
atual
do
vitiligo,
visando
avaliar
as
possibilidades
tratamento.
Materiais,
sujeitos
métodos:
Para
a
elaboração
deste
foram
utilizados
artigos
científicos
publicados
referenciados
na
Medline/PubMED
entre
2021
2023.
Resultados
discussão:
A
diversos
tipos
formas
apresentação
clínica,
pautado
acordo
extensão
atividade
da
doença.
As
opções
incluem
uso
terapia
ultravioleta
B
banda
estreita
(NB-UVB),
imunossupressores
corticoides,
metotrexato,
azatioprina
Apremilast,
inibidores
calcineurina.
Considerações
finais:
No
apesar
longo,
bons
resultados
têm
sido
vistos
realizando
terapias
duplas,
associando
fototerapia
imunossupressores,
corticoides
ou
metotrexato
e/ou
Palmitoyl copper peptide and acetyl tyrosine complex enhances melanin production in both A375 and B16 cell lines
Minhua Hong,
No information about this author
Y. S. Gui,
No information about this author
Jiayao Xu
No information about this author
et al.
Biochemical and Biophysical Research Communications,
Journal Year:
2024,
Volume and Issue:
742, P. 151060 - 151060
Published: Nov. 28, 2024
Language: Английский
Impactos biopsicossociais enfrentados por pacientes com vitiligo: Uma revisão sistemática
Ana Clara Junqueira Tedeschi,
No information about this author
Júlia Sammour,
No information about this author
Bianca De Castro
No information about this author
et al.
LUMEN ET VIRTUS,
Journal Year:
2024,
Volume and Issue:
15(39), P. 1667 - 1677
Published: Aug. 6, 2024
Objective:
The
aim
of
this
review
was
to
report
current
knowledge
about
the
main
signs
and
symptoms
that
affect
quality
life
individuals
with
vitiligo.
Methodology:
searches
were
carried
out
through
in
PubMed
Central
(PMC)
databases.
Three
descriptors
used
combination
Boolean
term
"AND":
vitiligo;
life;
depression;
psychosocial
impact;
Medical
Psychology.
From
search,
275
articles
found,
which
subsequently
submitted
selection
criteria.
Of
which,
after
applying
inclusion
exclusion
criteria,
36
selected
from
database,
a
total
19
studies
compose
collection.
Discussion:
Thus,
denote
skin,
being
largest
organ
body,
is
crucial
for
personal
image
diseases
alter
its
pigmentation,
such
as
vitiligo,
reduce
life,
especially
young
people.
biological
embryonic
point
view,
skin
brain
have
an
intimate
relationship,
suggests
changes
it
can
be
associated
mental
health
problems,
exacerbating
or
triggering
dermatological
conditions,
culminate
nervousness,
decreased
self-confidence,
anxiety
even
depression.
Results:
It
known
there
may
biomarker
activity
severity
vitiligo
where
related
prevalence
psychiatric
creating
distortions.
In
summary,
multifactorial
autoimmune
disease,
would
generate
great
impact
on
lives
patients,
influencing
individual
self-image
way
world
will
perceive
it,
thus
resulting
worsening
life.
Language: Английский
Comparison of Efficacy of Oral Tofacitinib (JAK Inhibitor) Combined with Narrow Band UVB Vs Alone Oral Tofacitinib in Patient with Vitiligo at Tertiary Care Hospital, Karachi
Soonha Iqra,
No information about this author
Rabia Ghafoor,
No information about this author
Muhammad Tarish Abro
No information about this author
et al.
Indus journal of bioscience research.,
Journal Year:
2024,
Volume and Issue:
2(2), P. 1493 - 1497
Published: Dec. 31, 2024
Objective:
compare
the
oral
Tofacitinib
added
to
NB-UVB
phototherapy
versus
monotherapy
in
patients
with
vitiligo,
at
a
tertiary
care
teaching
hospital
Karachi.
Methods:
After
ethical
approval
from
institutional
review
board,
this
open-label,
non-randomized
study
is
conducted
Department
of
Dermatology,
JPMC,
Karachi
April
2024
Sep
2024.
Through
non-probability
consecutive
sampling,
40
aged
18
above,
both
genders,
diagnosed
vitiligo
stable
lesions
for
half
year
were
included
present
study.
The
divided
into
groups:
Group
B
that
received
only
5
mg
twice
day
(n=20)
and
A
treated
combination
three
time
weekly
(n=20).
Results:
At
12
weeks,
VASI
score
showed
significant
improvement
+
group
(36.8
±
8.3)
compared
alone
(54.15
9.5,
p
<
0.0001).
percentage
was
also
significantly
higher
therapy
57.4
9.7%
36.7
9.9%
(p
Furthermore,
efficacy
outcome,
defined
as
≥51%
re-pigmentation,
achieved
15
(75%)
1
patient
(5%)
group,
highly
p-value
<0.0001.
Conclusion:
Oral
tofacitinib
complemented
more
effective
than
re-pigmentation
patients.
Language: Английский